Medexus Announces Closing of C$10 Million Bought-Deal Public Offering
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - October 6, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to...
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - October 6, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to...
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) today provides an update with respect to...
AI-powered technology will expand access to scans by enabling a broader set of healthcare providers to perform cardiac exams with...
Long-time Director Andrea Saia to retire from the BoardLONDON--(BUSINESS WIRE)--#advancedcirculatorysupport--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced its...
Four thousand healthcare solution users rated user experience among the top-performing category vendors in the 22 HIM-focused customer satisfaction surveys.BALTIMORE,...
DuraGraft is the first and only FDA cleared medical device for use as an intra-operative vascular conduit storage and flushing...
XI’AN, China, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of...
XI’AN, China, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of...
BOSTON, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”), a clinical-stage rare disease biopharmaceutical...
VANCOUVER, British Columbia, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that...
IRVINE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on...
Renowned Daner-Farber Cancer Institute researcher will advise on the development of IMUNON’s FixPlas™ and Indiplas™ modalities in immuno-oncology. LAWRENCEVILLE, N.J.,...
Chief Executive Officer, Amro Albanna to Present at 9:00am Eastern Time on Thursday, October 12, 2023Richmond, VA, Oct. 06, 2023...
Presentations Will Feature Data From ZETA-1 Phase 2 Trial of APX3330 in Diabetic RetinopathyFARMINGTON HILLS, Mich., Oct. 06, 2023 (GLOBE...
Locanabio expects to submit IND application in mid-2024 for first program, LBIO-115, designed to promote skipping of exon 51 in...
Expanded indication for ZORYVE provides new, steroid-free topical for children 6 to 11 with plaque psoriasis, including intertriginous psoriasisWESTLAKE VILLAGE,...
Jorge Masvidal Jorge Masvidal’s Gamebred Bareknuckle MMA Teams Up with Safety ShotSafety Shot to be ring sponsor for Gamebred matches...
MARKHAM, Ontario, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it...
California cannabis leader repurchases all outstanding senior secured convertible indebtednessSALINAS, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) -- Lowell Farms Inc....
BOUCHERVILLE, Québec, Oct. 06, 2023 (GLOBE NEWSWIRE) -- LSL Pharma Group Inc. (TSXV: LSL) – (the “Company” or “LSL Pharma...